Breaking News, Trials & Filings

SGS to Initiate Malaria Challenge Trial in Belgium

Trial to test the efficacy of MMV’s experimental compound in killing malaria parasites in the liver before they can develop and reach the bloodstream

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

SGS will begin its first malaria volunteer infection study (VIS) in Belgium on behalf of Medicines for Malaria Venture (MMV), a product development partnership (PDP) working in the field of anti-malarial drug research. The study will assist in the development of an advanced candidate compound from the anti-malarial drug pipeline developed by MMV and partners, which is a potential long-acting injectable chemoprotective drug.    The primary objective of the trial is to test the efficacy of MMV’s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters